NCT00549120View on ClinicalTrials.gov

Optimising the Propranolol Block Model

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 15, 2007

Primary Completion Date

October 26, 2007

Study Completion Date

October 26, 2007

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Propranolol

40 mg tablets

DRUG

Salbutamol

Metered dose inhaler (600 μg)

DRUG

Ipratropium

Metered dose inhaler (40 μg)

DRUG

Placebo

Placebo for propranolol tablets

Trial Locations (1)

Unknown

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY